COMMUNIQUÉS West-GlobeNewswire
-
Range Impact and C2 Ventures Launch AI Infrastructure Platform on 9,000-Acre West Virginia Energy Corridor
01/07/2026 -
Memphis Surgeon Seeks to Overturn Conviction, Citing FDA Guidance on Medical Devices with National Experts Aghast at Overzealous Persecution Despite FDA Safe Harbor
01/07/2026 -
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2026 -
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2026 -
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/07/2026 -
Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements
01/07/2026 -
Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences
01/07/2026 -
Compass Health recognized as a Quasquicentennial Corporation, marking 125 Years of service in Northwest Washington
01/07/2026 -
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
01/07/2026 -
She Had No Clue, Until She Did: Clue's new campaign spotlights seven women who found the missing piece behind years of symptoms, questions and hormonal uncertainty
01/07/2026 -
Applied Biologics Announces Expanded Strategic Focus on Surgical Applications of XWRAP®
01/07/2026 -
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
01/07/2026 -
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
01/07/2026 -
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
01/07/2026 -
Rentschler Biopharma appoints Dr. Torsten Woehr as Chief Executive Officer
01/07/2026 -
Managing Mental Health During the Summer
01/07/2026 -
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
01/07/2026 -
Medline to report second quarter 2026 results on August 5, 2026
01/07/2026 -
Safe Legal Steroid Alternatives: CrazyBulk Announces 2026 Legal Steroids For Muscle Growth and Strength Available In USA
01/07/2026
Pages